Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 30 n° 315

Gamida Cell to Present at Upcoming Investor Conferences

Posted by fidest press agency su domenica, 18 marzo 2018

Gamida Cell, a leading cellular and immune therapeutics company, today announced that the company will participate in two upcoming investor conferences: Julian Adams, Ph.D., chairman and chief executive officer, will share a company overview at the Oppenheimer 28th Annual Healthcare Conference at 2:45 p.m. on Wednesday, March 21, 2018, at the Westin New York Grand Central in New York, NY. Dr. Adams will also present at BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference at 9:30 a.m. ET on Friday, March 23, 2018, at the Millennium Broadway Hotel & Conference Center in New York, NY. A breakout session will follow the presentation at 10:00 a.m. The webcast can be accessed live: http://wsw.com/webcast/biocentury5/gamida.
A webcast of each presentation can be accessed through the links above, or from the News section of the Gamida Cell website.
Gamida Cell is a leader in cellular and immune therapeutics dedicated to treating patients with cancer and rare genetic diseases. The company is building a diverse pipeline based on its proprietary NAM technology platform to deliver transformative medicines to patients in need of new treatment options.

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: